Holen Sie sich die Stockscreener-App
5.545
0.70%
0.035
Schlusskurs vom Vortag:
$5.51
Offen:
$5.4
24-Stunden-Volumen:
1.87M
Relative Volume:
0.42
Marktkapitalisierung:
$1.98B
Einnahmen:
$9.68M
Nettoeinkommen (Verlust:
$-250.64M
KGV:
-3.9613
EPS:
-1.3998
Netto-Cashflow:
$-89.83M
1W Leistung:
+5.69%
1M Leistung:
+55.43%
6M Leistung:
+20.36%
1J Leistung:
+226.39%
1-Tages-Spanne:
$5.38
$5.68
1-Wochen-Bereich:
$5.255
$5.795
52-Wochen-Spanne:
$1.47
$6.04
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
5.545 | 1.96B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
505.47 | 132.55B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
665.30 | 70.90B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
911.25 | 57.21B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
324.06 | 42.94B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.98 | 40.49B | 742.00K | -1.37B | -1.07B | -7.0731 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Precigen Inc (NASDAQ:PGEN) Flashes Perfect Technical Rating and Explosive Sales Growth in Minervini Screen - ChartMill
Precigen Inc. (PGEN) Edges Higher as Biotech Sector Attention IntensifiesMotive Wave - dars.gov.et
Precigen reports $3.4M in PAPZIMEOS sales for Q4 2025 - Investing.com
PGENPrecigen Inc Latest SEC Filings - Finviz
Precigen Insider Sold Shares Worth $2,042,864, According to a Recent SEC Filing - marketscreener.com
Precigen Insider Sold Shares Worth $1,113,143, According to a Recent SEC Filing - Moomoo
Precigen CFO Harry Thomasian Jr. sells $1.1m in company stock - Investing.com UK
Insider Sell Alert: Harry Thomasian Sells 200,000 Shares of Prec - GuruFocus
Precigen CEO Helen Sabzevari sells $2.04m in PGEN stock - Investing.com
Precigen COO Rutul Shah sells $251,105 in company stock - Investing.com
Precigen (PGEN) COO sells 42,924 shares after option exercise - Stock Titan
Precigen COO Rutul Shah sells $251,105 in company stock By Investing.com - Investing.com South Africa
Precigen CEO Helen Sabzevari sells $2.04m in PGEN stock By Investing.com - Investing.com India
[Form 4] PRECIGEN, INC. Insider Trading Activity - Stock Titan
Form 4 Precigen Inc For: 1 July By Investing.com - Investing.com Canada
Precigen (PGEN) CFO executes 200,000-share open-market sale under 10b5-1 plan - Stock Titan
Form 144 PRECIGEN For: 1 July By Investing.com - Investing.com Nigeria
PGEN (NASDAQ) affiliate files Rule 144 notice to sell 28,571 shares - Stock Titan
Does Precigen’s (PGEN) Russell Value Index Exit Signal a Shifting Investor Base or Story? - simplywall.st
[144] PRECIGEN, INC. SEC Filing - Stock Titan
Form 144 PRECIGEN For: 29 June By Investing.com - Investing.com South Africa
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2000 Value Benchmark - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 2500 Value Benchmark - marketscreener.com
Precigen, Inc.(NasdaqGS: PGEN) dropped from Russell 3000E Value Benchmark - marketscreener.com
Precigen: Entering The Oncology "Sweet Spot" (NASDAQ:PGEN) - Seeking Alpha
PGEN Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Precigen, Inc. – NASDAQ:PGEN - TradingView
Precigen Inc Actuals & Estimates (BX:I5X) - TradingView
Price to earnings forward of Precigen, Inc. – NASDAQ:PGEN - TradingView
Precigen Shareholders Expand Incentive Plan, Reaffirm Governance - The Globe and Mail
Precigen (PGEN) investors back 7M-share incentive pool and all board picks - Stock Titan
Clearfield And 2 Insider Picks For Strong Growth - simplywall.st
Precigen (PGEN) Is Up 12.1% After Orphan Exclusivity Win for PAPZIMEOS TherapyWhat's Changed - Sahm
Precigen stock hits 52-week high at 5.47 USD By Investing.com - Investing.com Australia
Precigen stock hits 52-week high at 5.47 USD - Investing.com
Precigen (PGEN) Ends 11.6% Higher — This FDA Approval Could Hold the Reason - Insider Monkey
Precigen Gains FDA Orphan Drug Exclusivity for Gene Therapy Candidate PAPZIMEOSDebt Analysis Report - Město Břeclav
Precigen (PGEN) Secures FDA Orphan Drug Exclusivity for PAPZIMEOS - Insider Monkey
PGEN News | PRECIGEN INC (NASDAQ:PGEN) - ChartMill
Precigen Inc (PGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PGEN: All proposals, including board elections and compensation, passed overwhelmingly without shareholder questions - TradingView
PGEN: All proposals, including board elections and compensation, passed overwhelmingly without dissent - TradingView
Precigen Inc Annual Shareholders Meeting Transcript - GuruFocus
Precigen Inc (PGEN) Institutional Confidence - TradingKey
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Precigen Inc-Aktie (PGEN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thomasian Harry Jr. | Chief Financial Officer |
Jun 29 '26 |
Sale |
5.78 |
28,571 |
165,140 |
525,964 |
| Shah Rutul R | Chief Operating Officer |
Jun 29 '26 |
Option Exercise |
2.33 |
42,924 |
100,013 |
540,675 |
| Shah Rutul R | Chief Operating Officer |
Jun 29 '26 |
Sale |
5.85 |
42,924 |
251,105 |
497,751 |
| Sabzevari Helen | President and CEO |
Jun 29 '26 |
Option Exercise |
2.33 |
346,836 |
808,128 |
4,115,708 |
| Sabzevari Helen | President and CEO |
Jun 29 '26 |
Sale |
5.89 |
346,836 |
2,042,864 |
3,768,872 |
3.07%
6.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):